Uniogen
Uniogen develops next-generation diagnostics solutions for cancer detection and infection diagnosis.
Funding rounds
3/2024
Valuation after latest round
€19.3 million
Springvest's ownership stake
2.2% (31 December 2025)
Sector
Life sciences
Explore other companies
1/1